Dumas, P., Leclerc, M., Hunault, M., Tavernier, E., Pautas, C., Bertoli, S., Leguay, T., Tavitian, S., Raffoux, E., Hospital, M., Chantepie, S., Heiblig, M., CarrĂ©, M., Peterlin, P., Hernanz, M. P. G., Guieze, R., Simand, C., Turlure, P., Huynh, A., Lemasle, E., Gabellier, L., Lambert, J., Lebon, D., Uzunov, M., Malfuson, J., Cluzeau, T., Chraibi, S., Sanhes, L., Celli-Lebras, K., Mineur, A., Gardin, C., Ifrah, N., Vey, N., Latour, R. P. D., Luquet, I., Penther, D., Delabesse, Ă., Hamel, J., Itzykson, R., Preudhomme, C., Botton, S. D., Duployez, N., Pigneux, A., Dombret, H., RĂ©cher, C. (2025). Impact of midostaurin in younger AML patients intensively treated with high-dose anthracycline. Blood. https://doi.org/10.1182/blood-2025-1682